Evidence map›Paper›PMID 41318765›Full record

ArticleScientific reports2025

HyperFusionNet combines vision transformer for early melanoma detection and precise lesion segmentation.

Min Li, Yinping Jiang, Ge Cao, Tao Xu, Ruiqiang Guo

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Min LiThe Keimyung Academy at ChangChun University, Jilin, 130022, China.
Yinping JiangCollege of Electronic and Information Engineering, Changchun University, Jilin, 130022, China.
Ge CaoCollege of Electronic and Information Engineering, Changchun University, Jilin, 130022, China.
Tao XuCollege of Electronic and Information Engineering, Changchun University, Jilin, 130022, China.
Ruiqiang GuoCollege of Mechanical and Vehicle Engineering, Changchun University, Jilin, 130022, China. liminccutchi@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early and accurate diagnosis of melanoma remains a major challenge due to the heterogeneous nature of skin lesions and the limitations of traditional diagnostic tools. In this study, we introduce HyperFusion-Net, a novel hybrid deep learning architecture that synergistically integrates a Multi-Path Vision Transformer (MPViT) and an attention U-Net to simultaneously perform melanoma classification and lesion segmentation in dermoscopic images. Unlike conventional CNN-based methods, HyperFusion-Net combines the general feature extraction capabilities of transducers with the spatial accuracy of the U-Net, which is enhanced by a mutual attention fusion block that facilitates the effective fusion of semantic and spatial features. The model was trained and evaluated using four public ISIC datasets containing over 60,000 dermoscopic images. Preprocessing techniques such as hair removal, clipping, and normalization were applied to improve robustness. Experimental results show that HyperFusion-Net consistently outperforms state-of-the-art models including U-Net, DeepLabV3 + , TransUNet, and Swin-UNet, achieving superior performance in classification (accuracy: 93.24%, AUC: 95.80%) and segmentation (Dice coefficient: 0.945 in ISIC 2024). Ablation studies confirm the effectiveness of the multi-path design and fusion strategy in enhancing diagnostic performance while maintaining computational efficiency. Furthermore, the model demonstrates strong generalizability across datasets with different lesion types and imaging conditions.

Indexed as

DermoscopyEarly Detection of CancerImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedMelanomaSkin NeoplasmsAlgorithmsDeep LearningHumansDermoscopic imagesHybrid deep learningLesion segmentationMedical image analysisMelanoma detectionSkin cancer diagnosisVision transformer

Identifiers

PMID41318765
PMCPMC12775028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.